3rd Quarter - Report
FORBES-TATE for GENENTECH
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| DERRICK M WHITE | — |
Copyright/Patent/Trademark CPT
Intellectual property and process patent issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| DERRICK M WHITE | — |
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug reimportation; Issues related to RX drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| DERRICK M WHITE | — |
Medical/Disease Research/Clinical Labs MED
Issues related to Right to Try; Issues related to Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, S. 2852.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY DRISCOLL | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| DERRICK M WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.